Research Project · Health
Accelerating Hope: Clinical Trials for Hard-to-Treat Cancers Award
Children's Cancer Research Fundchildrenscancer.org (opens in a new tab)Catalog updated
- Amount
- $1,000,000
- Program type
- Research Project
- Field
- Health
- Eligible career stages
- Not listed
About this program
Children’s Cancer Research Fund is soliciting applications for the Accelerating Hope: Clinical Trials for Hard-to-Treat Cancers Award to support Phase 0–Phase 2 clinical trials targeting pediatric cancers or molecular/demographic subgroups with <70% five‑year survival, funding up to $1,000,000 total costs for projects of up to 36 months. A required Letter of Intent is due August 7, 2026 (invited full proposals due November 16, 2026) and full applications must include a detailed clinical protocol, a FAIR-compliant data sharing plan, and human subjects/IACUC approvals. Eligible principal investigators must hold a paid appointment at a U.S.-based nonprofit research, medical, or academic institution (U.S. citizenship not required), commit a minimum of 10% effort to the project, and may submit only one LOI per calendar year; the award is made to a single institution. CCRF will not fund research using human embryonic stem cells or fetal tissue.
In FundFit
FundFit names the researchers at your institution who match this program, and shows the eligibility rules, the announcement, and 50 or more similar programs in full.
Ask for a demo of this program The form opens already filled in.